These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20182437)

  • 21. [From classic to new bronchopulmonary dysplasia].
    Kramer BW; Lievense S; Been JV; Zimmermann LJ
    Ned Tijdschr Geneeskd; 2010; 154():A1024. PubMed ID: 20456770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased soluble ICAM-1 in tracheal aspirates of infants with bronchopulmonary dysplasia.
    Kojima T; Sasai M; Kobayashi Y
    Lancet; 1993 Oct; 342(8878):1023-4. PubMed ID: 8105265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Airway concentrations of angiopoietin-1 and endostatin in ventilated extremely premature infants are decreased after funisitis and unbalanced with bronchopulmonary dysplasia/death.
    Thomas W; Seidenspinner S; Kramer BW; Kawczyńska-Leda N; Chmielnicka-Kopaczyk M; Marx A; Wirbelauer J; Szymankiewicz M; Speer CP
    Pediatr Res; 2009 Apr; 65(4):468-73. PubMed ID: 19127216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
    Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation.
    Kazzi NJ; Brans YW; Poland RL
    Pediatrics; 1990 Nov; 86(5):722-7. PubMed ID: 2235226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia.
    Skinner AM; Battin M; Solimano A; Daaboul J; Kitson HF
    Am J Perinatol; 1997 Oct; 14(9):539-46. PubMed ID: 9394163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary endostatin perinatally and in lung injury of the newborn infant.
    Janér J; Andersson S; Haglund C; Lassus P
    Pediatrics; 2007 Jan; 119(1):e241-6. PubMed ID: 17158946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.
    Cummings JJ; D'Eugenio DB; Gross SJ
    N Engl J Med; 1989 Jun; 320(23):1505-10. PubMed ID: 2657423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia.
    van Mastrigt E; Zweekhorst S; Bol B; Tibboel J; van Rosmalen J; Samsom JN; Kroon AA; de Jongste JC; Reiss IKM; Post M; Pijnenburg MW
    PLoS One; 2018; 13(1):e0185969. PubMed ID: 29346372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dexamethasone therapy in bronchopulmonary dysplasia].
    Merz U; Kuehl G; Linderkamp O
    Klin Padiatr; 1989; 201(1):11-5. PubMed ID: 2495383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased interleukin-8 and monocyte chemoattractant protein-1 concentrations in mechanically ventilated preterm infants with pulmonary hemorrhage.
    Baier RJ; Loggins J; Kruger TE
    Pediatr Pulmonol; 2002 Aug; 34(2):131-7. PubMed ID: 12112780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exhaled breath condensate nitrite in premature infants with bronchopulmonary dysplasia.
    Yen E; Weinberger BI; Laumbach RJ; Ohman-Strickland PA; Vetrano AM; Gow AM; Ramagopal M
    J Neonatal Perinatal Med; 2018; 11(4):399-407. PubMed ID: 30040745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia.
    Hsiao CC; Chang JC; Tsao LY; Yang RC; Chen HN; Lee CH; Lin CY; Tsai YG
    Pediatr Neonatol; 2017 Feb; 58(1):63-69. PubMed ID: 27321203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysfunction of pulmonary surfactant in chronically ventilated premature infants.
    Merrill JD; Ballard RA; Cnaan A; Hibbs AM; Godinez RI; Godinez MH; Truog WE; Ballard PL
    Pediatr Res; 2004 Dec; 56(6):918-26. PubMed ID: 15496605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventilatory management and bronchopulmonary dysplasia in preterm infants.
    Gupta S; Sinha SK; Donn SM
    Semin Fetal Neonatal Med; 2009 Dec; 14(6):367-73. PubMed ID: 19766071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants.
    Rozycki HJ; Byron PR; Elliott GR; Carroll T; Gutcher GR
    Pediatr Pulmonol; 2003 May; 35(5):375-83. PubMed ID: 12687595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eosinophil cationic protein in tracheal aspirates of preterm infants with bronchopulmonary dysplasia.
    Raghavender B; Smith JB
    J Pediatr; 1997 Jun; 130(6):944-7. PubMed ID: 9202617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of inhaled steroids in the treatment of bronchopulmonary dysplasia.
    Avent ML; Gal P; Ransom JL
    Neonatal Netw; 1994 Apr; 13(3):63-9. PubMed ID: 7512192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone does not affect vasopressin release in bronchopulmonary dysplasia.
    Zanardo V; Golin R; Chiozza ML; Faggian D
    Pediatr Nephrol; 2000 Dec; 15(3-4):241-4. PubMed ID: 11149118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.